APPLICATIONS PUBLISHED 5 NOVEMBER 2003
Published: 1-Apr-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T+43 1521 260 F+43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T+43 1521 260 F+43 1 52126 4492
Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
Quark Biotech; Shionogi 1357881*
Use of alkylpolyxylosides as emulsifying agents for preparing water-in-oil emulsions
S.E.P.P.I.C. Societe d'Expolitation de Produits pour les Industries Chimiques 1357894*
Vaccine compsn and stabilisation method
Aventis Pasteur 1357895*
Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartifical organ comprising same
Association pur les transfert de technologie Du Mans; Universite Catholique de Louvain; Center Europeen D'Etude du Diabete 1357896*
Delivery of biologically active agents
Medical Research Council 1357897*
Improved controlled release oral dosage form
ANDRX Pharmaceuticals 1357898*
Oral itraconazole formulations and methods of making the same
DSM IP Assets 1357899*
Process for the preparation of nanoparticles and microparticles by spray freezing into liquid
Board of Regents, the University of Texas System 1357900*
Process
AstraZeneca 1357901*
Therapeutic agents complexed with calcium phosphate and encased by casein
Biosante Pharmaceuticals 1357902*
Stabilised formulations of 6-hydroxy-3-(4- 2-(piperidin-1-yl) ethoxy]-phenoxy)-2-(4-methoxyphenyl) benzo B]thiophene and salts thereof
Eli Lilly 1357903*
Use of pyrazolo [ 4,3-D]pyrimidines
Merck Patent 1357904*
A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
Kamm, Michael Albert 1357905*
Blockage of calcium channels by phenol derivatives
B Braun Melsungen 1357906*
Method of treating the syndrome of coronary heart disease risk factors in humans
CPD 1357907*
Acyl sulphamides for treatment of obesity, diabetes and lipid disorders
Merck 1357908*
IL-8 receptor antagonists
SmithKline Beecham Corp 1357909*
Method for preventing and treating visceral pain and gastrointestinal disorders
Warner-Lambert 1357910*
Use of betaine in functional products having blood pressure lowering effects
Finnfeeds Finland 1357911*
Photodynamic therapy of occult choroidal neovascularisation linked to age-related macular degeneration
QLT; Novartis 1357912*
Heterocyclic inhibitors of glycine transporter 2
Telik 1357913*
Treatment of PPAR mediated diseases
SmithKline Beecham Corp 1357914*
Pharmaceutical formulation comprising pyrazolo [4,3-D]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists
Merck Patent 1357915*
Two-component anti-emetic compsn dexamethasone and metoclopramide
Odyssey Pharmaceuticals 1357916*
Use of carbohydrates for eliminating intestinal infections in animals
Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt 1357917*
Metabolic controlled fermentation process for carbamoyl tobramycin production
Biogal Gyogyszergyar 1357918*
Therapy-enhancing glucan
Sloan-Kettering Institute for Cancer Research 1357919*
Compsns and methods of tissue superoxygenation
Hydron Technologies 1357920*
Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom
Kemin Industries; Plethodon Research 1357921*
Cell suspension preparation technique and device
McComb Foundation 1357922*
Herbal compsn for the prevention and treatment of dementia
Neuromedix; Jung, Jang-Huyn 1357923*
Antiviral compsn made from medicinal plants for combating HIV/AIDS
Gbodossoum, Erick Vidjin' Agnih 1357924*
Compsns containing an active fraction isolated from Hedyotis diffusae and methods of use
Wackycom 1357925*
Local use of ethereal oils
Walther Schoenenberger Pfanzensaftenwerk; Heiss, Markus M; Tarabichi, Anwar 1357926*
Cholesterol-lowering agent
Societe des Produits Nestle 1357927*
A novel pharmaceutical compound and methods of making and using same
New River Pharmaceuticals 1357928*
Keratinocyte growth factor-2
Human Genome Sciences 1357931*
Crystal modification of a cyclic depsipeptide having improved strength
Bayer 1357932*
Modified erythropoietin (EPO) with reduced immunogenicity
Merck 1357933*
Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity
Merck Patent 1357934*
Method of reducing side effects of chemotherapy in cancer patients
Sciclone Pharmaceuticals 1357935*
Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interface
The Board of Regents of the University of Michigan 1357936*
Use of a botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthritis, epiconylitis and rotator muscle cap pathology
Universita' Degli Studi di Udine 1357937*
Hyperblebbing bacterial strains and use thereof for production of vaccines
SmithKline Beecham Biologics 1357938*
Haemophilus influenza BASB212 polynucleotides, polypeptides and use thereof
GlaxoSmithKline Biologicals 1357939*
Hepatitis B virus treatment
Stressgen Biotechnologies Inc 1357940*
Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases
SmithKline Beecham 1357941*
Methods and compsns for treatment of immune dysfunction disorders
The Lauridsen Group 1357942*
Methods and compsns for modulating the immune systems of animals
The Lauridsen Group 1357943*
Perylenequinones for use with immunotherapy agents
Altachem Pharma 1357944*
Method to prevent vision loss
QLT; Novartis 1357945*
Reduced fluence rate PDT
QLT 1357946*
Novel compsns of potassium channel openers and protein kinase C inhibitors and use thereof
Pharmacia 1357974*
Medicament compsns with negligible side-effects containing beta-mimetics
Boehringer Ingelheim Pharma 1357975*
Pharmaceutical compsns having few side-effects
Boehringer Ingelheim Pharma 1357976*
Chromium-containing compsns for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesterolemia
Nutrition 21 1357977*
Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
Glaxo Group 1358152*
Ophthalmic compsns for treating ocular hypertension
Merck 1358153*
Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
Abbott Laboratories 1358154*
Aromatic sulphonyl alpha-cycloamino hysroxamates and their use as MMP inhibitors
Pharmacia 1358155*
Benz(G) indoles and their use as SPLA2 inhibitors
Eli Lilly 1358156*
Carbazole derivatives and their use as neuropeptide Y5 receptor ligands
AstraZeneca 1358157*
N-substituted tetrahydropyridines and their use as pesticides
Syngenta Participations 1358158*
3,4-diaminopyridine tartrate and phosphate, pharmaceutical compsns and uses thereof
Assistance Publique, Hopitaux de Paris; Guyon, Francois; Pradeau. Dominique; Le Hoang, My Dung; Houri, Jean-Jacques 1358159*
Aminal diones as potassium channel openers
Abbot Laboratories 1358160*
N-pyridyl carboxamide derivatives and pharmaceutical compsns containing them
Amgen 1359161*
Dihydroindole and tetrahydroquinoline derivatives
F Hoffmann-la Roche 1358162*
Melancortin receptor agonists
Eli Lilly 1358163*
Method of producing 1-alkyl-3-aryl-5-diflurormethoxy-1H-pyrazoles
BASF 1358164*
Imidazole derivatives
F Hoffmann-La Roche 1358165*
Process for the preparation of triazinylaminostilbene-disulphonic acid compounds
Ciba Specialty Chemicals Holding 1358166*
Novel 2-benzoxazolyl benzene derivatives and their use as UV screening agents
Roche Vitamins 1358167*
Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
F Hoffmann-La Roche 1358168*
Diaminothiazoles and their use as cyclin-dependent kinase
F Hoffmann-La Roche 1358169*
Process for preparing higher primary alkanols
Cilag 1358170*
Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compsns and novel use
Aventis Pharma 1358171*
Amino ceramide-like compounds and therapeutic methods of use
The Regents of the University of Michigan 1358172*
Method for producing optically active, propargylic terminal epoxides
Forschungszentrum Juelich 1358173*
Inhibitors of cruzipain and other cysteine proteases
Amura Therapeutics 1358174*
Phenoxy substituted benzo-condensed heteroaryl derivatives
Karo Bio 1358175*
Inhibitors of cruzipain and other cysteine proteases
Amura Therapeutics 1358176*
Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
Neurosearch 1358177*
Sulphonide lactam inhibitors of factor XA
Bristol-Myers Squibb 1358178*
Synthesis method and intermediates of pyridin-2-yl-methylamine
Pierre Fabre Medicament 1358179*
Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
F Hoffmann-La Roche 1358180*
Substituted pyrrolidines as CCR-3 receptor antagonists
F Hoffmann-La Roche 1358181*
Diazocine derivatives and their use as tryptase inhibitors
Byk Gulden Lomberg Chemische Fabrik 1358182*
Cysteine protease inhibitors
Medivir 1358183*
Substituted alkylamide derivatives and methods of use
Amgen 1358184*
Pyridoarylphenyl oxazolidinone antibacterials and related compounds and methods
Ortho-McNeil Pharmaceuticals 1358185*
Laulimalide derivatives
Kosan Biosciences 1358186*
Naphthyridine derivatives
Glaxo Group 1358187*
Antagonists of MCP-1 function and methods of use thereof
Telik; Sanwa Kagaku Kenkyusho 1358188*
Process for the preparation of a pyrazolo [ 4,3-D]pyrimidine derivative
Merck Patent 1358189*
Amorphous organic 1,3,2-dioxaborine luminophores, method for the production and use thereof
Siemens 1358190*
